Polymorphisms in Cyclooxygenase , Lipoxygenase , and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial (2023)
Attributed to:
HDHL-Biomarkers: Fatty Acid Metabolism - Interlinking Diet with Cardiometabolic Health (FAME)
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1940-6207.capr-23-0111
PubMed Identifier: 37756582
Publication URI: http://europepmc.org/abstract/MED/37756582
Type: Journal Article/Review
Parent Publication: Cancer Prevention Research
Issue: 11
ISSN: 1940-6215